| Name | Title | Contact Details |
|---|
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
BreezoMeter offers personalized air quality & pollen data as well as active fire alerts with worldwide coverage & accuracy down to the street level.
PaxeraMed Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Franklin Group Inc is a Somerville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Place for Children with Autism provides a comprehensive approach to autism treatment that focuses on the highest quality therapy to enrich the lives of children with autism and their families across all communities. Utilizing one-to-one ABA therapy in a structured, center-based environment, our programs are designed with quality as the priority and support as the ongoing means to achieve it. We specialize in all developmental areas to help children build independence and school readiness skills to succeed. The Place for Children with Autism works with families from all economic backgrounds to find options that fit their needs.